Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Alere (2017)
Tendyne Holdings (2017) Walk Vascular (2021) Alere Inc. (2017) Cardio MEMS (2014) Medi Sense (1996) St. Jude Medical (2017) Knoll Pharmaceuticals (2001) Neuro Sphere (2021) Solvay Pharmaceuticals (2010) Zebra Medical Vision (2020) |
| gptkbp:ceo |
gptkb:Robert_B._Ford
|
| gptkbp:employees |
113,000 (2020)
|
| gptkbp:founded |
1888
|
| gptkbp:founder |
gptkb:Wallace_Calvin_Abbott
|
| gptkbp:global_presence |
Over 160 countries
|
| gptkbp:headquarters |
gptkb:Abbott_Park,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abbott Laboratories
|
| gptkbp:industry |
Healthcare
|
| gptkbp:market_cap |
$200 billion (2021)
|
| gptkbp:market_launch |
Alinity (2019)
Free Style Libre (2014) Panbio COVID-19 Antigen Test (2020) Similac Pro-Advance (2018) Tacti Cath (2019) |
| gptkbp:net_income |
$3.5 billion (2020)
|
| gptkbp:operating_income |
$7.5 billion (2020)
|
| gptkbp:partnership |
gptkb:Global_Fund
gptkb:World_Health_Organization gptkb:Gavi,_the_Vaccine_Alliance gptkb:UNICEF |
| gptkbp:products |
Medical devices
Nutrition Pharmaceuticals Diagnostics |
| gptkbp:research_and_development |
$2.1 billion (2020)
|
| gptkbp:revenue |
$43.1 billion (2020)
|
| gptkbp:stock_symbol |
ABT
|
| gptkbp:subsidiary |
gptkb:Abbott_Vascular
gptkb:St._Jude_Medical |
| gptkbp:website |
www.abbott.com
|
| gptkbp:bfsParent |
gptkb:W3_C
|
| gptkbp:bfsLayer |
3
|